Data Foundry

Drug recalls 2016

Gildess 1/20 — Class III drug recall D-0120-2017

Completed recall by Par Pharmaceutical, Inc., reported 2016-11-09, distributed nationwide. Subpotent Drug; Ethinyl Estradiol

Recall numberD-0120-2017
Product typeDrug
ClassificationClass III
StatusCompleted
Voluntary or mandatedVoluntary
Recalling firmPar Pharmaceutical, Inc., Chestnut Ridge, NY, United States
Recall initiated2016-09-27
Classified2016-11-01
Reported by FDA2016-11-09
DistributedNationwide (US)
Quantity393,981 tablets
Reason classespotency
NDC00603-7607-15, 00603-7607-48
Lot numbers4101059, 4101062, 4187113, 4187114, 4187115, 4190273, 4190274, 4190280, 4190536, 4265203, 4265204, 4265205, 4359294, 4359296, 4367922, 4379814, 4403535, 4403536, 4501265, 4501267, 4506357, 4563352, 4563353, 4572326, 4572327, 4572328, 4627845, 4651818, 4731571, 4731572, 4731573, 4798704, 4798705, 4936585

Product

Gildess 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0,02 mg, USP), 21 count, (a) 3 blisters (NDC 0603-7607-48) and (b) 6 blisters (NDC 0603-7607-15), Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST PHARMACEUTICALS, USA, Huntsville, AL 35811

Reason for recall

Subpotent Drug; Ethinyl Estradiol

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0120-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.